Eva M Sevick-Muraca Selected Research

IRDye800

2/2015	Preclinical characterization and validation of a dual-labeled trastuzumab-based imaging agent for diagnosing breast cancer.
9/2005	Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe.
10/2004	Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva M Sevick-Muraca Research Topics

Disease

27	Neoplasms (Cancer) 04/2022 - 11/2003
9	Neoplasm Metastasis (Metastasis) 09/2015 - 07/2008
8	Breast Neoplasms (Breast Cancer) 08/2022 - 11/2003
7	Lymphedema (Milroy Disease) 08/2020 - 05/2011
6	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 02/2012
5	Melanoma (Melanoma, Malignant) 10/2018 - 10/2004
3	Lymphatic Metastasis 08/2020 - 02/2012
3	Inflammation (Inflammations) 03/2014 - 01/2013
3	Heterotopic Ossification (Ectopic Ossification) 10/2011 - 12/2010
3	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2005 - 10/2004
2	Endocarditis 01/2017 - 04/2014
2	Wounds and Injuries (Trauma) 01/2016 - 07/2013
2	Infections 04/2014 - 03/2014
2	Glioma (Gliomas) 08/2010 - 07/2005
1	Venous Insufficiency 01/2021
1	Myocardial Infarction 01/2019
1	Varicose Ulcer (Ulcer, Venous) 01/2016
1	Leg Ulcer 01/2016
1	Ulcer 01/2016
1	Hypoplastic Left Heart Syndrome 10/2014
1	Pleural Effusion (Pleural Effusions) 10/2014
1	Lymphatic Diseases 01/2014
1	Lymphocele 05/2013
1	Carcinoma (Carcinomatosis) 09/2012
1	Hypertension (High Blood Pressure) 08/2012
1	Breast Cancer Lymphedema 07/2010

Drug/Important Bio-Agent (IBA)

9	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 03/2008
7	Contrast MediaIBA 01/2016 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2011
5	Monoclonal AntibodiesIBA 01/2017 - 11/2003
4	Epithelial Cell Adhesion MoleculeIBA 02/2015 - 05/2012
4	Coloring Agents (Dyes)IBA 05/2013 - 10/2004
4	IRDye 800CWIBA 05/2012 - 03/2007
4	Fluorescent Dyes (Fluorescent Probes)IBA 07/2008 - 04/2005
4	ErbB Receptors (EGF Receptor)IBA 09/2007 - 11/2003
4	CY5.5 cyanine dyeIBA 03/2007 - 11/2003
3	Pharmaceutical PreparationsIBA 01/2019 - 04/2013
3	Trastuzumab (Herceptin)FDA Link 02/2015 - 09/2007
3	human ERBB2 proteinIBA 02/2015 - 09/2007
3	IRDye800IBA 02/2015 - 10/2004
3	Epidermal Growth Factor (EGF)IBA 07/2008 - 11/2003
3	IntegrinsIBA 07/2005 - 04/2005
2	Indicators and Reagents (Reagents)IBA 08/2020 - 09/2012
2	Vascular Endothelial Growth Factor CIBA 10/2018 - 07/2013
2	Pentetic Acid (DTPA)FDA LinkGeneric 02/2015 - 09/2007
2	CytokinesIBA 10/2013 - 01/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 01/2013
2	fluorescent protein 583IBA 09/2012 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 06/2011 - 09/2007
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2010 - 09/2007
2	Hematoxylin (Haematoxylon)IBA 10/2010 - 09/2007
1	AntigensIBA 04/2022
1	gallium arsenide (GaAs)IBA 08/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018
1	Fimbriae Proteins (Pilin)IBA 01/2017
1	Glycoside Hydrolases (Endoglycosidases)IBA 04/2015
1	Polysaccharides (Glycans)IBA 04/2015
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2015
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 02/2015
1	Immunoconjugates (Immunoconjugate)IBA 02/2015
1	AntibodiesIBA 04/2014
1	Peptidoglycan (Murein)IBA 04/2014
1	LipidsIBA 03/2014
1	Complement System Proteins (Complement)IBA 07/2013
1	SaltsIBA 08/2012
1	EstersIBA 05/2012
1	DOTA-NHSIBA 05/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2011
1	HydrogelsIBA 12/2010
1	Indium-111IBA 07/2008
1	Immunoglobulin G (IgG)IBA 09/2007
1	arginyl-glycyl-aspartyl-phenylalanineIBA 09/2005
1	IndiumIBA 09/2005
1	Integrin beta3 (GPIIIa)IBA 09/2005
1	Cyclic PeptidesIBA 09/2005
1	Biological ProductsIBA 10/2004
1	Integrin alphaVbeta3IBA 10/2004
1	Peptides (Polypeptides)IBA 10/2004
1	Cetuximab (Erbitux)FDA Link 11/2003

Therapy/Procedure

8	Therapeutics 01/2019 - 11/2003
4	Radiotherapy 08/2022 - 03/2012
3	Lymph Node Excision (Lymph Node Dissection) 08/2022 - 12/2013
3	Intradermal Injections 01/2021 - 08/2010
2	Immunotherapy 04/2022 - 01/2019
2	Intravenous Administration 02/2015 - 01/2010
2	Manual Lymphatic Drainage 03/2012 - 05/2011
2	Intravenous Injections 05/2005 - 04/2005
1	Pleurodesis 10/2014
1	Chest Tubes (Chest Tube) 10/2014
1	Injections 12/2013
1	Microspheres (Microsphere) 12/2010
1	Subcutaneous Injections 07/2008